Viewing Study NCT02499445



Ignite Creation Date: 2024-05-06 @ 7:14 AM
Last Modification Date: 2024-10-26 @ 11:46 AM
Study NCT ID: NCT02499445
Status: COMPLETED
Last Update Posted: 2015-07-16
First Post: 2015-03-05

Brief Title: Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery
Sponsor: Konkuk University Medical Center
Organization: Konkuk University Medical Center

Study Overview

Official Title: Comparisons of Myocardial Injury After Using Different Anesthetics Regimens for Off-pump Coronary Artery Bypass Surgery Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimen
Status: COMPLETED
Status Verified Date: 2015-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In patients undergoing off-pump coronary artery bypass OPCAB surgery with different anesthesia regimens remifentanil 075 mcgkgmin and propofol TCI effect-site concentration 08-15 mcgml Group -RP remifentanil 075 mcgkgmin and sevoflurane end-tidal 08 vol Group-RS or sevoflurane end-tidal 12-28 vol-sufentanil TCI effect site concentration 035-075 ngml Group-SS intergroup difference in the level of Troponin I c-TnI and creatinine kinase subtype-MB is determined before surgery control during vascular graft harvesting harvesting after completing graft construction postgrafting and one day after surgery postoperative
Detailed Description: To determine the difference of myocardial injury upon using different anesthesia regimens remifentanil-based regimen versus sevoflurane-sufentanil balanced regimen

Patients undergoing off-pump coronary artery bypass OPCAB surgery are randomly allocated to get remifentanil 075 mcgkgmin and propofol TCI effect-site concentration 08-15 mcgml Group -RP remifentanil 075 mcgkgmin and sevoflurane end-tidal 08 vol Group-RS or sevoflurane end-tidal 12-28 vol-sufentanil TCI effect site concentration035-075 ngml Group-SS

Intergroup difference in the level of Troponin I c-TnI and creatine kinase-MB is determined before surgery control during vascular graft harvesting harvesting after completing graft construction postgrafting 1 day after surgery postoperative

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None